Multimodal Imaging for Early Functional Response Assessment of 90Y-/177Lu-DOTATOC Peptide Receptor Targeted Radiotherapy with DW-MRI and 68Ga-DOTATOC-PET/CT

被引：0
|
作者：
Sarah Wulfert
Clemens Kratochwil
Peter L. Choyke
Ali Afshar-Oromieh
Walter Mier
Hans-Ulrich Kauczor
Jens-Peter Schenk
Uwe Haberkorn
Frederik L. Giesel
机构：
[1] University Hospital Heidelberg,Department of Nuclear Medicine
[2] NCI,Molecular Imaging Program
[3] University Hospital Heidelberg,Department of Diagnostic and Interventional Radiology
来源：
Molecular Imaging and Biology | 2014年 / 16卷
关键词：
Peptide receptor-targeted radiotherapy; Multimodal imaging; Neuroendocrine cancer; Response monitoring; 68Ga-DOTATOC PET; DW-MRI;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：586 / 594
页数：8
相关论文
共 13 条
  • [1] Multimodal Imaging for Early Functional Response Assessment of 90Y-/177Lu-DOTATOC Peptide Receptor Targeted Radiotherapy with DW-MRI and 68Ga-DOTATOC-PET/CT
    Wulfert, Sarah
    Kratochwil, Clemens
    Choyke, Peter L.
    Afshar-Oromieh, Ali
    Mier, Walter
    Kauczor, Hans-Ulrich
    Schenk, Jens-Peter
    Haberkorn, Uwe
    Giesel, Frederik L.
    MOLECULAR IMAGING AND BIOLOGY, 2014, 16 (04) : 586 - 594
  • [2] 68Ga DOTATOC PET/CT for treatment response of Peptide Receptor Radionuclide Therapy using 177Lu and 90Y-DOTATOC
    Finocchiaro, D.
    Grassi, E.
    Fioroni, F.
    Castellani, G.
    Lanconelli, N.
    Versari, A.
    Filice, A.
    Iori, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S288 - S288
  • [3] Peptide receptor radionuclide therapy with Y-90 DOTATOC and Lu-177 DOTATATE in patients with progressive meningioma and prognostic value of pretherapeutic Ga-68 DOTATOC/-TATE PET/CT
    Ilhan, Harun
    Seystahl, Katharina
    Veit, Stoecklein
    Schueller, Ulrich
    Rushing, Elisabeth
    Nicolas, Guillaume
    Schaefer, Niklaus
    Pangalu, Athina
    Lehner, Sebastian
    Bartenstein, Peter
    Michael, Weller
    Tonn, Joerg
    Sommerauer, Michael
    Albert, Nathalie
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [4] Diffusion-weighted MRI and (68)Ga-DOTATOC PET for early monitoring of response to intraarterial(90)Y-/(177)Lu-DOTATOC therapy in patients with neuroendocrine liver metastases
    Giesel, F.
    Wulfert, S.
    Kuder, T.
    Kauczor, H.
    Schwartz, L.
    Haberkorn, U.
    Kratochwil, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S289 - S289
  • [5] Subacute and Long-Term Hepatotoxicity Risk after 90Y-OR 177LU-DOTATOC Therapy - Is Hepatic Tumour Burden on 68Ga-DOTATOC PET/CT Predictive of Liver Dysfunction?
    Chirindel, A.
    Anongpornjossakul, Y.
    Wild, D.
    Nicolas, G.
    NEUROENDOCRINOLOGY, 2019, 108 : 204 - 204
  • [6] Diffusion- weighted MRI and Ga68-DOTATOC PET for early monitoring of response to intra-arterial Y90/Lu177-DOTATOC therapy in patients with neuroendocrine liver metastases
    Giesel, Frederik
    Wulfert, Sarah
    Kuder, Tristan
    Schwartz, Lawrence
    Kauczor, Hans-Ulrich
    Haberkorn, Uwe
    Kratochwil, Clemens
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [7] Organ-specific response to [177Lu]DOTATATE peptide receptor radionuclide therapy (PRRT) assessed by sequential [68Ga]DOTATOC PET/CT in patients with metastatic small intestine neuroendocrine tumors
    Bessac, Darejan Mamulashvili
    Baltzinger, Philippe
    Poterszman, Nathan
    Van, Floriane Pham
    Collen, Cedric
    Malouf, Gabriel G.
    Ouvrard, Eric
    Kaseb, Ashjan
    Porot, Clemence
    Ben Abdelghani, Meher
    Addeo, Pietro
    Mertz, Luc
    Goichot, Bernard
    Imperiale, Alessio
    ENDOCRINE, 2025, 87 (03) : 1333 - 1341
  • [8] Concordance between baseline 68Ga-DOTATOC PET/CT and first post-dose 177Lu-oxodotreotide SPECT/CT (177Lu-DOTATATE-SPECT/CT) images in patients with neuroendocrine tumors (NETs) treated with peptide receptor radionuclide therapy (PRRT)
    Cardozo Saavedra, A.
    Simo-Perdigo, M.
    Garcia-Burillo, A.
    Villasboas-Rosciolesi, D.
    Hernando, J.
    Capdevila, J.
    Menendez-Sanchez, S.
    Bellviure-Meiro, R.
    Dellepiane-Clarke, F.
    Aguade-Bruix, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S466 - S467
  • [9] Morphologic and metabolic response assessment of 177Lu-DOTA-TATE peptide receptor radionuclide therapy (PRRT) with 68Ga-DOTA-TOC PET/CT
    Gaertner, F. C.
    Hillerer, C.
    Lapa, C.
    Miederer, M.
    D'Alessandria, C.
    Wester, H.
    Schwaiger, M.
    Scheidhauer, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S267 - S267
  • [10] Comparison of 68Ga-DOTATATE PET/CT for Assessment of Response to Peptide Receptor Radionuclide Therapy after 2 and 4 Cycles of 177Lu-DOTATATE: Preliminary Single Academic Center Experience
    Song, H.
    Kunz, P.
    Fisher, G.
    Franc, B.
    Moradi, F.
    Davidz, G.
    Iag, A.
    Aparic, Mari C.
    NEUROENDOCRINOLOGY, 2020, 110 : 273 - 273
12